Research Project
Grant-in-Aid for Scientific Research (B)
Mig-6 acts as an inhibitor of EGF signaling via binding with the EGF receptor (EGFR). Downregulated expression of the Mig-6 gene is observed in breast carcinomas, in which it correlates with reduced overall survival. Mig-6-deficient mice show hyperactivation of endogenous EGFR and develop spontaneous tumors in various organs. Therefore, Mig-6 is an important tumor suppressor. However, its post-translational modifications and regulatory mechanisms have not been elucidated. Here, we investigated the phosphorylation of human Mig-6 and found that Chk1 phosphorylated Mig-6 in vivo as well as in vitro. Moreover, EGF stimulation promoted phosphorylation of Mig-6 without DNA damage and the phosphorylation was inhibited by depletion of Chk1. EGF also increased Ser280-phosphorylated Chk1, a cytoplasmic-tethering form, via PI3K pathway. Mass spectrometric analyses suggested that Ser 251 of Mig-6 was a major phosphorylation site by Chk1 in vitro and in vivo. Substitution of Ser 251 to alanine increased inhibitory activity of Mig-6 against EGFR activation. Moreover, EGF-dependent activation of EGFR and cell growth were inhibited by Chk1-depletion, and were rescued by co-depletion of Mig-6. Our results suggest that Chk1 phosphorylates Mig-6 on Ser 251, resulting in the inhibition of Mig-6, and that Chk1 acts a positive regulator of EGF signaling. This is a novel function of Chk1.
All 2013 2012 2011 2010 Other
All Journal Article (36 results) (of which Peer Reviewed: 15 results) Presentation (15 results) (of which Invited: 1 results) Remarks (4 results) Patent(Industrial Property Rights) (2 results)
実験医学増刊号
Volume: 31 Pages: 33-38
Sci Transl Med
Volume: 4 Pages: 1-10
EMBO J
Volume: 31 Pages: 2365-2377
Curr. Drug Targets
Volume: 13 Pages: 1616-1621
Volume: 13 Pages: 1641-1648
Curr. Drug Target
Volume: 13 Pages: 1588-1592
PLoS ONE
Volume: 7
CurrentMedicinal Chemistry (review article)
Volume: 19 Pages: 893-900
Sci. Transl. Med.
Volume: 4 Issue: 163
10.1126/scitranslmed.3004655
Cell Mol Life Sci
Volume: (in press) Issue: 18 Pages: 3277-3289
10.1007/s00018-012-1232-x
EMBO J.
Volume: 31 Issue: 10 Pages: 2365-2377
10.1038/emboj.2012.88
Volume: 13 Issue: 13 Pages: 1616-1621
10.2174/138945012803530026
Volume: 13 Issue: 13 Pages: 1641-1648
10.2174/138945012803529974
Volume: 13 Issue: 13 Pages: 1588-1592
10.2174/138945012803529965
Current Medicinal Chemistry
Genes Cells
Volume: 16 Pages: 1110-1120
Oncogene
Volume: 30 Pages: 1956-1962
Development
Volume: 138 Pages: 1771-1782
J. Cell Sci
Volume: 124 Pages: 2816-2825
Volume: 30 Issue: 16 Pages: 1110-1120
10.1038/onc.2010.568
Volume: 16 Issue: 11 Pages: 1110-1120
10.1111/j.1365-2443.2011.01553.x
実験医学
Volume: 29 Pages: 1716-1721
細胞工学
Volume: 20 Pages: 729-733
Cell Div
Volume: 5 Pages: 27-27
120005305355
Biochem. Biophys. Res. Commun
Volume: 403 Pages: 194-197
Volume: 400 Pages: 271-277
Biol. Pharm. Bull
Volume: 33 Pages: 1112-1116
Int. J. Cancer
Volume: 127 Pages: 1517-1525
Ther. Med
Volume: 1 Pages: 695-699
Cell Division
Biochem.Biophys.Res.Commun.
Biol.Pharm.Bull.
Int.J.Cancer
Exp.Ther.Med.
Volume: 1 Pages: 595-699
http://www.hama-med.ac.jp/uni_education_igakubu_igaku_seika1.html
http://www2.hama-med.ac.jp/w1a/bio1/index-j.html